drugset / Trial / NCT01837433

Short-term Prednisone to Treat STA Study(SPTSS)

NCT01837433

Phase 4 Completed 40 enrolled Xinqiao Hospital of Chongqing
RandomizedParallel-groupSingle-blindTreatment

Summary

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis The investigators hypothesize that less adverse reactions will be observed, comparing with the guidelines recommend. The recurrence rate, adrenal insufficiency, temporary and permanent hypothyroidism aren't significant difference.

Timeline

Start
2013-03
Primary completion
2014-12
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 30 mg Oral
Background Celecoxib Other / unclassified 200 mg

Indications